Table 2.
Covariates and their association with successful human-to-mosquito abdomen infection by DENV-1 or DENV-2 in multivariable regression analysis
Variable | OR (95% CI) | P |
Day of illness (+1 d) | 0.60 (0.46–0.80) | 0.0005 |
Viremia (+1 log10-copies/mL) | 2.97 (2.29–3.86) | <0.0001 |
Serotype DENV-2 (vs. DENV-1) | 0.80 (0.44–1.44) | 0.46 |
Serology | ||
Secondary (vs. primary) | 0.94 (0.52–1.70) | 0.83 |
Indeterminate (vs. primary) | 1.86 (0.78–4.41) | 0.16 |
Antirecombinant DIII IgG titer (twofold increase) | 0.88 (0.78–0.99) | 0.03 |
IgM units (twofold increase) | 0.66 (0.53–0.82) | 0.0002 |